Envista Holdings (NVST) Shares Outstanding (2018 - 2026)
Envista Holdings (NVST) posted quarterly Shares Outstanding (Entity) of $176.2 million for Q2 2026, up 0.74% year-over-year from $174.9 million in Q2 2025, and little changed quarter-over-quarter from $175.4 million in Q4 2025.
Envista Holdings (NVST) Shares Outstanding (2018 - 2026) Analysis & Trends
Envista Holdings' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $176.2 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 0.74% year-over-year to $176.2 million; the TTM figure through Apr 2026 stood at $176.2 million (up 0.74% YoY), while the FY2025 annual figure was $175.4 million, up 0.69% from the prior year.
- Shares Outstanding (Entity) for Q2 2026 stood at $176.2 million, roughly flat from $175.4 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $176.2 million in Q2 2026, with the low at $163.2 million in Q2 2022.
- The 5-year median for Shares Outstanding (Entity) is $173.8 million (2024), against an average of $170.7 million.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) increased 5.87% in 2023, then advanced 0.46% in 2024.
- Envista Holdings' Shares Outstanding (Entity) stood at $163.7 million in 2022, then climbed by 5.86% to $173.3 million in 2023, then climbed by 0.52% to $174.2 million in 2024, then gained by 0.69% to $175.4 million in 2025, then grew by 0.46% to $176.2 million in 2026.
- Business Quant data shows NVST's Shares Outstanding (Entity) at $176.2 million in Q2 2026, $175.4 million in Q4 2025, and $175.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Envista Holdings | 4.40 Bn | 3.27 Bn | 407.00 Mn | 161.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 161.90 Mn |
| Apr 3, 2026 | 163.90 Mn |
| Dec 31, 2025 | 168.00 Mn |
| Sep 26, 2025 | 166.10 Mn |
| Jun 27, 2025 | 169.00 Mn |
| Mar 28, 2025 | 172.40 Mn |
| Dec 31, 2024 | 172.20 Mn |
| Sep 27, 2024 | 172.20 Mn |
| Jun 28, 2024 | 172.10 Mn |
| Mar 29, 2024 | 171.90 Mn |
| Dec 31, 2023 | 166.90 Mn |
| Sep 29, 2023 | 168.20 Mn |
| Jun 30, 2023 | 164.00 Mn |
| Mar 31, 2023 | 163.60 Mn |
| Dec 31, 2022 | 162.90 Mn |
| Sep 30, 2022 | 163.10 Mn |
| Jul 1, 2022 | 162.90 Mn |
| Apr 1, 2022 | 162.20 Mn |
| Dec 31, 2021 | 161.20 Mn |
| Oct 1, 2021 | 161.50 Mn |